Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation

  • Vago L
  • Perna S
  • Zanussi M
  • et al.
434Citations
Citations of this article
284Readers
Mendeley users who have this article in their library.

Abstract

Transplantation of hematopoietic stem cells from partially matched family donors is a promising therapy for patients who have a hematologic cancer and are at high risk for relapse. The donor T-cell infusions associated with such transplantation can promote post-transplantation immune reconstitution and control residual disease.

Cite

CITATION STYLE

APA

Vago, L., Perna, S. K., Zanussi, M., Mazzi, B., Barlassina, C., Stanghellini, M. T. L., … Fleischhauer, K. (2009). Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation. New England Journal of Medicine, 361(5), 478–488. https://doi.org/10.1056/nejmoa0811036

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free